ОЦЕНКА СЕРДЕЧНО-СОСУДИСТОГО ЗДОРОВЬЯ: СТАРЫЕ ФАКТОРЫ — НОВАЯ МОДЕЛЬ
https://doi.org/10.15829/1728-8800-2015-5-87-93
Аннотация
Сердечно-сосудистые заболевания (ССЗ) занимают ведущие позиции среди основных причин смерти во всем мире. В 2009г Американской Ассоциацией Сердца была разработана модель сердечно-сосудистого здоровья (СС здоровья), введено понятие "идеального", "среднего" и "слабого" СС здоровья. При оценке СС здоровья учитываются 7 показателей: уровень глюкозы, холестерина, артериального давления, отказ от курения, индекс массы тела, физическая активность и правильное питание. После создания этой модели были проведены исследования по оценке ее эффективности, а также эффективности проводимых профилактических мероприятий. Стало известно, что распространенность "идеального" СС здоровья в популяции очень мала, <1%, и необходимо учитывать количество "идеальных" показателей, которое может служить сильным предиктором не только заболеваемости, но и смертности от ССЗ. Таким образом, внедрение этой шкалы позволит снизить заболеваемость и смертность от ССЗ, путем разработки мер по созданию здорового образа жизни у детей, подростков и лиц молодого возраста, а также повышению восприимчивости населения к понятию здорового образа жизни.
Об авторах
А. Э. Имаева
ФГБУ "Государственный научно-исследовательский центр профилактической медицины" Минздрава России. Москва, Россия
Россия
Россия
к. м.н., с. н.с. лаборатории экономического анализа эпидемиологических исследований и профилактических технологий отдела эпидемиологии
С. А. Шальнова
ФГБУ "Государственный научно-исследовательский центр профилактической медицины" Минздрава России. Москва, Россия
Россия
руководитель отдела эпидемиологии хронических неинфекционных заболеваний
Россия
руководитель отдела эпидемиологии хронических неинфекционных заболеваний
Список литературы
1. World Health Organization. Cardiovascular disease: The atlas of heart disease and stroke. 2015
2. The Demographic Yearbook of Russia. 2013. Federal State Statistical Service (Rosstat). Moscow, 2013. Russian (Демографический ежегодник России. Росстат, Москва 2013).
3. Mozaffarian D, Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: Heart disease and stroke statistics—2015 update: A report from the American Heart Association. Circulation 2015; 131(4), 434-41.
4. Shalnova SA, Deev AD. Russian mortality trends in the early XXI century: official statistics data. Cardiovascular Therapy and Prevention 2011; 10 (6): 5-10. Russian (Шальнова С. А., Деев А. Д. Тенденции смертности в России в начале XXI века (по данным официальной статистики. Кардиоваскулярная терапия и профилактика 2011; 10(6);5-10).
5. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart Disease and Stroke Statistics 2012 Update: A Report From the American Heart Association. Circulation 2012; 125: e2-e220.
6. Lloyd-Jones DM, Hong Y Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121(4): 586-613.
7. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21-181.
8. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol 1991; 1(3): 263-76.
9. Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med 2012; 19(4): 403-88.
10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
11. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-72.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30(suppl 1): S42-7.
13. 2008 Physical Activity Guidelines for Americans. Washington, DC: US Dept of Health and Human Services; 2008.
14. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans, 2005. 6th ed. Washington, DC: US Government Printing Office; 2005.
15. Johnson RK, Appel LJ, Brands M, et al. On behalf of the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and Prevention. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 2009; 120: 1011-20.
16. Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307(5): 491-7.
17. Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014; 311(2): 183-92.
18. Folsom AR, Yatsuya H, Nettleton JA, et al. Community Prevalence of Ideal Cardiovascular Health, by the AHA Definition, and Relation to Cardiovascular Disease Incidence. JACC 2011; 57(16): 1690-6.
19. Yang Q, Cogswell ME, Flanders WD, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 2012; 307(12): 1273-83.
20. Robbins JM, Petrone AB, Carr JJ, et al. Association of ideal cardiovascular health and calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J 2015; 169(3): 371-8.
21. Xanthakis V, Enserro DM, Murabito JM, et al. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation 2014; 130(19): 1676-83.
22. Crichton GE, Elias MF, Robbins MA. Cardiovascular health and arterial stiffness: the Maine-Syracuse Longitudinal Study. J Hum Hypertens 2014; 28(7): 444-9.
23. Kim JY, Ko YJ, Rhee CW. Cardiovascular health metrics and all-cause and cardiovascular disease mortality among middle-aged men in Korea: the Seoul male cohort study. J Prev Med Public Health 2013; 46(6): 319-28.
24. Yan Liu, Hong-jie Chi, Liu-fu Cui, et al. The ideal cardiovascular health metrics associated inversely with mortality from all causes and from cardiovascular diseases among adults in a Northern Chinese Industrial City. PLoS One 2014; 9(2): e89161.
25. World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press; 2008.
26. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763-74.
27. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003; 54: 248-61.
28. Khalaila R, Litwin H. Changes in health behaviors and their associations with depressive symptoms among Israelis aged 50+. J Aging Health 2014; 26(3): 401-21.
29. Kronish IM, Carson AP, Davidson KW, et al. Depressive symptoms and cardiovascular health by the American Heart Association's definition in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. PLoS One 2012; 7(12): e52771.
30. Feighner JP. Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 1995; 56: 574-9.
31. Lin EH, Katon W, Rutter C, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med 2006; 4: 46-53.
32. Espana-Romero V, Artero EG, Lee DC, et al. A prospective study of ideal cardiovascular health and depressive symptoms. Psychosomatics 2013; 54(6): 525-35.
33. Li Z, Yang X, Wang A, et al. Association between Ideal Cardiovascular Health Metrics and Depression in Chinese Population: A Cross-sectional Study. Sci Rep 2015; 5: 11564.
34. Crichton GE, Elias MF, Davey A, Alkerwi A. Cardiovascular health and cognitive function: the Maine-Syracuse Longitudinal Study. PLoS One 2014; 9(3): e89317.
35. Huffman MD, Capewell S, Ning H, et al. Cardiovascular Health Behavior and Health Factor Changes (1988 -2008) and Projections to 2020: Results From the National Health and Nutrition Examination Surveys. Circulation 2012; 125(21): 2595-602.
36. Mozaffarian D, Afshin A, Benowitz NL, et al. AHA Scientific Statement Population Approaches to Improve Diet, Physical Activity, and Smoking Habits A Scientific Statement From the American Heart Association. Circulation 2012; 18; 126(12).
37. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309(1): 71-82.
38. Wu CY Chou YC, Huang N, et al. Association of body mass index with all-cause and cardiovascular disease mortality in the elderly. PLoS One 2014; 9(7): e102589.
39. Auyeung TW, Lee JS, Leung J, et al. This may bear significant implication on the recommended cutoff values for BMI and WHR in the older population. J Gerontol A Biol Sci Med Sci 2010; 65(1): 99-104.
40. Hastie CE, Padmanabhan S, Slack R, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010; 31(2): 222-6.
Рецензия
Для цитирования:
Имаева А.Э., Шальнова С.А. ОЦЕНКА СЕРДЕЧНО-СОСУДИСТОГО ЗДОРОВЬЯ: СТАРЫЕ ФАКТОРЫ — НОВАЯ МОДЕЛЬ. Кардиоваскулярная терапия и профилактика. 2015;14(5):87-93. https://doi.org/10.15829/1728-8800-2015-5-87-93
For citation:
Imaeva A.E., Shalnova S.A. CARDIOVASCULAR HEALTH EVALUATION: FORMER FACTORS — NOVEL MODEL. Cardiovascular Therapy and Prevention. 2015;14(5):87-93. (In Russ.) https://doi.org/10.15829/1728-8800-2015-5-87-93
Просмотров:
934
Послать статью по эл. почте 
